Evaluation of Targeted Agents for Advanced and Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
Conclusions: According to current evidence, lenvatinib and apatinib had superior clinical effects for patients without previously systematic treatments, and regorafenib seemed to be more suitable for patients with previously targeted agent therapies. However, our conclusions still need more statistical validations, and more high-quality trials are expected.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Tao Guo, Pengpeng Liu, Jian Yang, Ping Wu, Baiyang Chen, Zhisu Liu, Zhen Li Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Hepatocellular Carcinoma | Liver Cancer | Statistics | Study